RYAN (Ryan Specialty Holdings) 5-Year EBITDA Growth Rate: 27.90% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RYAN Ryan Specialty Holdings Inc RYAN
81 GF Score
Price $43.87
GF Value $79.92
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Ryan Specialty Holdings 5-Year EBITDA Growth Rate?

Ryan Specialty Holdings RYAN +0.85% 81 5-Year EBITDA Growth Rate is 27.90% as of Jun. 2026. GuruFocus rates RYAN with a GF Score™ of 81/100 and a GF Value™ of $79.92 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Ryan Specialty Holdings's EBITDA per Share for the three months ended in Jun. 2026 was $1.95.

During the past 12 months, Ryan Specialty Holdings's average EBITDA Per Share Growth Rate was 21.60% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 57.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 27.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Ryan Specialty Holdings was 57.70% per year. The lowest was 0.20% per year. And the median was 25.35% per year.


Ryan Specialty Holdings  (NYSE:RYAN) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Ryan Specialty Holdings 5-Year EBITDA Growth Rate Related Terms


RYAN vs RDN, ESNT, MTG: 5-Year EBITDA Growth Rate Comparison

For the Insurance - Specialty subindustry, Ryan Specialty Holdings's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ryan Specialty Holdings 5-Year EBITDA Growth Rate vs Insurance Industry

For the Insurance industry and Financial Services sector, Ryan Specialty Holdings's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Ryan Specialty Holdings's 5-Year EBITDA Growth Rate falls into.


RYAN
81GF Score
Ryan Specialty Holdings Inc RYAN
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ryan Specialty Holdings 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 27.90% mean?
Ryan Specialty Holdings (RYAN) has a 5-Year EBITDA Growth Rate of 27.90% as of Jun. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Ryan Specialty Holdings and its competitors.
Is Ryan Specialty Holdings' 5-Year EBITDA Growth Rate too high?
Ryan Specialty Holdings' current 5-Year EBITDA Growth Rate is 27.90%. Overall, Ryan Specialty Holdings has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ryan Specialty Holdings' 5-Year EBITDA Growth Rate compare to RDN and ESNT?
Ryan Specialty Holdings' 5-Year EBITDA Growth Rate of 27.90% can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for an Insurance company?
A good 5-Year EBITDA Growth Rate depends on the Insurance industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Ryan Specialty Holdings and its competitors. Ryan Specialty Holdings's current 5-Year EBITDA Growth Rate is 27.90%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ryan Specialty Holdings stock overvalued right now?
Based on GuruFocus' analysis, Ryan Specialty Holdings (RYAN) is currently considered Significantly Undervalued. The stock's GF Value™ is $79.92, compared to a current price of $43.87 — trading 45.1% below its estimated fair value. The current 5-Year EBITDA Growth Rate is 27.90%. Ryan Specialty Holdings' overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Ryan Specialty Holdings (RYAN), the current 5-Year EBITDA Growth Rate is 27.90% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ryan Specialty Holdings (RYAN) Overvalued in 2026?

Based on GuruFocus' analysis, Ryan Specialty Holdings stock appears to be undervalued. The current stock price of $43.87 is trading 45.1% below its estimated GF Value™ of $79.92. GuruFocus considers Ryan Specialty Holdings to be Significantly Undervalued.

Key valuation signals for RYAN:

  • 5-Year EBITDA Growth Rate: 27.90%
  • GF Value™: $79.92 vs. price of $43.87 (45.1% below fair value)
  • GF Score™: 81/100 with 5 warning signs

No single metric tells the full story. See the RYAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ryan Specialty Holdings Business Description

Address 155 North Wacker Drive, Suite 4000, Chicago, IL, USA, 60606
Ryan Specialty Holdings Inc is an international specialty insurance intermediary providing specialty products, solutions, and services for insurance brokers, agents, and carriers. The company offers wholesale insurance brokerage and delegated underwriting authority products and services, including distribution, underwriting, product development, administration, and risk management. Its expertise spans property, casualty, professional lines, transportation, personal lines, workers compensation, and employee benefits insurance, across traditional insurance and alternative risk solutions. The company operates in the United States and foreign markets, with the majority of revenue generated from the United States.
81GF Score

Get the complete analysis for RYAN

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$43.87
Price
$79.92
GF Value